The European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitors
Eur Heart J
.
2015 Dec 27:ehv673.
doi: 10.1093/eurheartj/ehv673.
Online ahead of print.
Authors
Eberhard Blind
1
,
Pieter A de Graeff
2
,
Illiana Meurs
2
,
Frank Holtkamp
2
,
Ania Baczynska
1
,
Heidi Janssen
1
Affiliations
1
European Medicines Agency, London, UK.
2
Dutch Medicines Evaluation Board, Utrecht, The Netherlands.
PMID:
26712836
DOI:
10.1093/eurheartj/ehv673
No abstract available